Navigation Links
Shareholders to Challenge Johnson & Johnson's Support for Left-Wing Policy Agenda: CEO William C. Weldon to Be Questioned on Firm's Failure to Disclose Financial Information on Firm's ObamaCare Lobbying It Pledged to Release Last Year
Date:4/27/2011

WASHINGTON, April 27, 2011 /PRNewswire-USNewswire/ -- The National Center for Public Policy Research will grill Johnson & Johnson executives over the firm's lobbying for bigger government Thursday, April 28 at the company's annual shareholder meeting in New Brunswick, New Jersey. National Center General Counsel Justin Danhof will demand specific answers about the company's pro-ObamaCare lobbying that Johnson & Johnson CEO William C. Weldon promised to provide but failed to do.

A National Center for Public Policy Research/FreedomWorks poll shows the pharmaceutical giant is vulnerable to a boycott by conservatives.

Johnson & Johnson's favorability among conservatives fell from 69 percent to 19 percent and from 60 percent to 8 percent among tea party activists after participants were informed of the company's lobbying or ObamaCare and cap-and-trade.

In addition to supporting Obama's health care takeover, Johnson & Johnson is a member of the U.S. Climate Action Partnership, a left-wing lobbying coalition formed to promote job-killing global warming regulations such as cap-and-trade.

"From the ObamaCare bill to cap-and-trade legislation, President Obama has been able to count on Johnson & Johnson for aid and comfort. By supporting Obama's economically disastrous policies, Johnson & Johnson is working to increase the power and scope of the federal government at the expense of American liberties and values. Weldon should explain why he is risking Johnson & Johnson's reputation, goodwill and shareholder value to promote a big-government agenda," said Danhof.

Johnson & Johnson is a member of the Pharmaceutical Researchers and Manufacturers of America (PhRMA), which aggressively lobbied for President Obama's health care takeover. At last year's Johnson & Johnson shareholder meeting, Weldon promised National Center Free Enterprise Project Director Dr. Tom Borelli that the firm would disclose precisely how much shareholder money his company spent promoting the ObamaCare legislation.

"Despite repeated requests from the National Center and his own pledge in front of shareholders last year, Weldon still refuses to release those figures. It is time for Weldon to come clean with company stakeholders - many of whom undoubtedly oppose the ObamaCare agenda," said Danhof.

At last year's shareholder meeting, Weldon told Dr. Borelli, "I don't think there is any reputational damage" due to the company's lobbying for ObamaCare's passage.

"The poll numbers don't lie. Tea party activists and conservatives have indicated a willingness to vote with their wallets and forgo Johnson & Johnson products. That could result in real economic loss for shareholders. Weldon needs to explain why he continues to oversee Johnson & Johnson's support of President Obama's unpopular policies instead of upholding his fiduciary duty and protecting the shareholders' investments in the company he is tasked to run," Danhof stated.

To view a transcript of CEO Weldon's conversation with Dr. Borelli at the 2010 shareholder meeting and subsequent communications, see: http://www.nationalcenter.org/ObamacareLobbying.pdf

For more details on the National Center for Public Policy Research/FreedomWorks poll, see: http://www.nationalcenter.org/teapartysurvey.pdf

CONTACT: David Almasi, +1-202-543-4110 x11, +1-703-568-4727, dalmasi@nationalcenter.org, or Judy Kent, +1-703-759-7476, jkent@nationalcenter.org


'/>"/>
SOURCE National Center for Public Policy Research
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Announces Chairmans Letter to Shareholders
2. Dehaier Medical Chairman and CEO Issues Letter to Shareholders
3. Wound Management Technologies President Writes Letter to Its Shareholders; Cites 3x Revenues Increase Over 2009; CellerateRX® Gaining Traction
4. AFSCME Urges Shareholders to Vote against Executive Compensation at Pfizer (PFE) and Johnson & Johnson (JNJ)
5. Omni Bio Pharmaceutical, Incs. CEO Issues Letter to Shareholders
6. Tongjitang Chinese Medicines Company Shareholders Vote to Approve Merger
7. Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation
8. Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split
9. Tongjitang Chinese Medicines Company Announces Extraordinary General Meeting of Shareholders
10. Caraco Announces Merger Agreement with Sun Pharma; Caraco Public Shareholders to Receive $5.25 Cash per Share
11. Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):